Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

why you might pretend that I chose to focus on the mild population I have no clue. We have been over this exact same point before- yes, at the start I did focus on the very flimsy data for all groups.

BUT as I have said: IP has NOT given us the data to compare the moderate subgroups!!!
Why give only data for 200mg moderate group? Where is the comparable info for placebo and 50 and 100 mg dose subsets?

In all recent posts on this topic this has been my focus- no revisiting of mild disease data, just this:

no way to compare results for moderate patients, no data provided . Why is that?

Whaddya say?